Schisandrin B inhibits epithelial ‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways
In conclusion, the present study demonstrated that SchB exerted inhibitory effects on large‑cell lung cancer cells via targeting the NF‑κB and p38 MAPK signaling pathways, suggesting that SchB may act as a potential therapeutic drug for large‑cell lung cancer.PMID:33907830 | DOI:10.3892/or.2021.8066
Source: Oncology Reports - Category: Cancer & Oncology Authors: Shuping Li Hong Wang Ruidong Ma Li Wang Source Type: research
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Lung Cancer | Stem Cell Therapy | Stem Cells | Study